{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "24073856",
  "DateCompleted": {
    "Year": "2014",
    "Month": "11",
    "Day": "06"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "10",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2013",
        "Month": "12",
        "Day": "13"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1089/thy.2013.0277"
    ],
    "Journal": {
      "ISSN": "1557-9077",
      "JournalIssue": {
        "Volume": "24",
        "Issue": "3",
        "PubDate": {
          "Year": "2014",
          "Month": "Mar"
        }
      },
      "Title": "Thyroid : official journal of the American Thyroid Association",
      "ISOAbbreviation": "Thyroid"
    },
    "ArticleTitle": "In vivo 5FU-exposed human medullary thyroid carcinoma cells contain a chemoresistant CD133+ tumor-initiating cell subset.",
    "Pagination": {
      "StartPage": "520",
      "EndPage": "532",
      "MedlinePgn": "520-32"
    },
    "Abstract": {
      "AbstractText": [
        "The hierarchical model of solid tumor proposes the existence of rare tumor cell subpopulations with stem-cell properties. The glycoprotein prominin-1 (CD133) represents one of the cancer stem-cell markers in several tumor types. The CD133+ cell subpopulation was shown to be enriched for tumor-initiating and highly chemoresistant cells in human cancer(s).",
        "We investigated whether CD133+ cells derived from human medullary thyroid carcinoma (MTC) possess tumor-initiating properties in vivo and exhibit differential responses to chemotherapeutic agents. We demonstrated that separated CD133+ cells from the human MTC cell line TT are enriched for tumor-initiating cells as demonstrated by tumor formation in vivo. Nevertheless, TT CD133+ cells do not exhibit increased chemoresistance in comparison to parental cells. However, when MTC xenotransplants were treated with the chemotherapeutic drug 5-fluorouracil (5FU) in vivo, CD133 expression increased in MTC cells.",
        "This cell line, designated FTTiv isolated from the drug-exposed xenotransplants, exhibits a significantly different response to 5FU associated with the substantial change in the expression profile of genes involved in 5FU metabolism and drug resistance. Moreover, the CD133+ tumor-initiating subpopulation derived from these drug-exposed FTTiv cells is significantly more resistant to 5FU and retains the chemoresistant properties upon FTTiv culture propagation.",
        "These data suggest that the chemoresistant phenotype and the CD133+ MTC subpopulation emerged in response to chemotherapy in vivo."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "1 Laboratory of Molecular Oncology, Cancer Research Institute , Slovak Academy of Sciences, Bratislava, Slovakia ."
          }
        ],
        "LastName": "Kucerova",
        "ForeName": "Lucia",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Feketeova",
        "ForeName": "Lucia",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kozovska",
        "ForeName": "Zuzana",
        "Initials": "Z"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Poturnajova",
        "ForeName": "Martina",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Matuskova",
        "ForeName": "Miroslava",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Nencka",
        "ForeName": "Radim",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Babal",
        "ForeName": "Pavel",
        "Initials": "P"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Thyroid",
    "NlmUniqueID": "9104317",
    "ISSNLinking": "1050-7256"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "AC133 Antigen"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antigens, CD"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antineoplastic Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Glycoproteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "PROM1 protein, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Peptides"
    },
    {
      "RegistryNumber": "U3P01618RT",
      "NameOfSubstance": "Fluorouracil"
    }
  ],
  "SupplMeshList": [
    "Thyroid cancer, medullary"
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "AC133 Antigen"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Antigens, CD"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Antineoplastic Agents"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Apoptosis"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Carcinoma, Medullary"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Carcinoma, Neuroendocrine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Line, Tumor"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Cell Transformation, Neoplastic"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Drug Resistance, Neoplasm"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Fluorouracil"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Glycoproteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug effects",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Neoplastic Stem Cells"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism"
      ],
      "DescriptorName": "Peptides"
    },
    {
      "QualifierName": [
        "genetics",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Thyroid Neoplasms"
    }
  ]
}